Regen BioPharma Inc (RGBP)

[falon]

KOOS has shown his hand:

Looking into the New Year I will work diligently towards the goal of entering into additional co-development projects and collaborations that I believe will benefit Regen's shareholders and I expect to identify a contract research organization that will help us move the Company's intellectual propriety towards clinical trials.



Status of LOI


T Minus 27 or sooner.

The Parties agree to negotiate in good faith to enter into a mutually acceptable definitive agreement with regard to the subject matter contemplated by this Letter until the completion of the Term (1/26/2022).

https://sec.report/Document/0001607062-21-000512/